Insulin degludec U100 is associated with lower risk for severe and symptomatic hypoglycemia as compared with insulin glargine U100 in subjects with type 1 diabetes.
about
Insulin degludec U100 is associated with lower risk for severe and symptomatic hypoglycemia as compared with insulin glargine U100 in subjects with type 1 diabetes.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Insulin degludec U100 is assoc ...... subjects with type 1 diabetes.
@en
Insulin degludec U100 is assoc ...... subjects with type 1 diabetes.
@nl
type
label
Insulin degludec U100 is assoc ...... subjects with type 1 diabetes.
@en
Insulin degludec U100 is assoc ...... subjects with type 1 diabetes.
@nl
prefLabel
Insulin degludec U100 is assoc ...... subjects with type 1 diabetes.
@en
Insulin degludec U100 is assoc ...... subjects with type 1 diabetes.
@nl
P2093
P2860
P356
P1476
Insulin degludec U100 is assoc ...... subjects with type 1 diabetes.
@en
P2093
Anastasios Tentolouris
Ioanna Eleftheriadou
Nikolaos Tentolouris
P2860
P356
10.21037/ATM.2017.12.28
P577
2018-02-01T00:00:00Z